INDO US BIOTECH
Back to Cashflow Statement
|
INDO US BIOTECH Last 5 Year Cash Flow from Operating Activities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹1.42 Cr | ₹-4.58 Cr | ₹0.53 Cr | ₹2.91 Cr | ₹0.22 Cr |
What is the latest Cash Flow from Operating Activities ratio of INDO US BIOTECH ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹1.42 Cr |
| Mar2024 | ₹-4.58 Cr |
| Mar2023 | ₹0.53 Cr |
| Mar2022 | ₹2.91 Cr |
| Mar2021 | ₹0.22 Cr |
How is Cash Flow from Operating Activities of INDO US BIOTECH Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹1.42 Cr | Positive | |
| Mar2024 | ₹-4.58 Cr | Negative | |
| Mar2023 | ₹0.53 Cr | -81.91 | |
| Mar2022 | ₹2.91 Cr | 1,192.44 | |
| Mar2021 | ₹0.22 Cr | - | |
Compare Cash Flow from Operating Activities of peers of INDO US BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDO US BIOTECH | ₹187.3 Cr | -4.9% | -15.4% | -37.3% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹4,500.9 Cr | 1.9% | -11% | -41.1% | Stock Analytics | |
| VENKYS (INDIA) | ₹1,943.1 Cr | -2.1% | -18.1% | -13.7% | Stock Analytics | |
| AVT NATURAL PRODUCTS | ₹1,069.0 Cr | 1.3% | 4.3% | 12.1% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹1,009.3 Cr | 0.7% | NA | NA | Stock Analytics | |
| MANGALAM GLOBAL ENTERPRISE | ₹549.0 Cr | 9.5% | 20.6% | 34.9% | Stock Analytics | |
INDO US BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDO US BIOTECH | -4.9% |
-15.4% |
-37.3% |
| SENSEX | -0.5% |
-4.3% |
-8.4% |
You may also like the below Video Courses